HealthTech Investor Summit 2025

Ad Hoc Clinical just wrapped up three energizing days in Utrecht, and still processing all the amazing insights from HealthTech Investor Summit 2025.

One of the highlights was Evelyne Vermeersch serving as a jury member during the start-up pitches. Being so close to early-stage innovation — and seeing founders defend their vision with such clarity and drive — is always a privilege.

What truly set this conference apart was the atmosphere: networking didn’t feel like an agenda item; it was simply happening everywhere, all the time. People connected easily, openly, and with real intent. The entire event felt like a living ecosystem in motion.

At Ad Hoc Clinical, we support HealthTech companies as they navigate clinical research, regulatory pathways, and European oversight. Events like hashtag#HIS25 reinforce how important it is to provide that solid backbone so innovators can focus on what they do best — building solutions that improve care.

Walking away from Utrecht, a few themes stayed with me:

 🔹 the power of honest dialogue,

 🔹 the momentum of promising technologies,

 🔹 and the impact of collaboration on clinical progress.

A big thank-you to Henk Joos, Ann Van Gysel, Rita Prota, and the whole Biovia team for bringing such a strong community together — and to everyone we had the pleasure of connecting with.

Excited to continue the conversations next year in Bruges for HIS 2026!